Dose of Indemnity for the COVID-19 Vaccine Manufacturers and it’s Effectiveness in India

  • Shreya Singh
  • Show Author Details
  • Shreya Singh

    Student in India.

  • img Download Full Paper


Amid the deadly chaos caused due to the Coronavirus, vaccines emerged as a boon for humanity. These vaccines have been produced at lightning speed. The leading vaccine manufacturers have been leading the vaccine industry, such as United States biotechnology company Moderna and German pharmaceutical company Pfizer. Further, the vaccines produced by these companies have been proven to be 95% effective in reducing the mortality rate due to Coronavirus. As the vaccines produced by these companies are in high demand, developed nations like the United States of America and the United Kingdom have granted indemnity to these companies from civil liability. In India, there are no such legal arrangements for vaccine manufacturers to escape criminal or civil liability. Thus, the purpose of this paper is to examine the viability of indemnity contracts with the vaccine manufacturers in India, considering that a similar demand for indemnity clause has been made by the Serum Institute of India, which has been producing vaccines for Coronavirus on a large scale in India.


Research Paper


International Journal of Law Management and Humanities, Volume 5, Issue 2, Page 1367 - 1373


Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution -NonCommercial 4.0 International (CC BY-NC 4.0) (, which permits remixing, adapting, and building upon the work for non-commercial use, provided the original work is properly cited.


Copyright © IJLMH 2021